Hepatocellular Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection
Conditions: Hepatocellular Carcinoma Interventions: Drug: Sintilimab; Drug: Lenvatinib; Procedure: Transarterial Chemoembolization (TACE) Sponsors: Tongji Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Conditions: Hepatocellular Carcinoma Interventions: Biological: Sintilimab; Procedure: Transarterial Chemoembolization (TACE) Sponsors: Tongji Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Device: Microwave ablation Sponsors: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

National Liver Cancer Biomarker Screening Trial
Conditions: Carcinoma, Hepatocellular; Liver Cancer; Liver Cirrhosis; Hepatitis B Interventions: Diagnostic Test: GALAD; Diagnostic Test: Liver Ultrasound with or without AFP Sponsors: University of Texas Southwestern Medical Center; National Cancer Institute (NCI); University of Pennsylvania; University of Michigan; Dana-Farber Cancer Institute; Baylor College of Medicine; Fred Hutchinson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Biological: AZD5851 Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Conditions: Hepatocellular Carcinoma; Pancreatic Ductal Adenocarcinoma; Biliary Tract Cancers; Esophageal Squamous Cell Carcinoma; Triple Negative Breast Cancer; Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer; Head and Neck Squamous-Cell Carcinoma Interventions: Drug: ABBV-400 Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Conditions: Solid Tumor, Adult; Solid Tumor; Gastric Cancer; Hepatocellular Carcinoma; Metastatic Colorectal Cancer; Advanced Solid Tumor Interventions: Drug: PB101 Sponsors: Panolos Bioscience Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Conditions: Liver Diseases; Hepatocellular Carcinoma; Immunotherapy; Lenvatinib; Sintilimab Interventions: Procedure: bTAE-HAIC; Drug: Lenvatinib; Drug: Sintilimab Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials

Follow up After TACE by Elastography and Color Doppler.
Conditions: Hepatocellular Carcinoma Interventions: Device: US Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials

Fostrox + Lenvima continues to show promising tumor control in Hepatocellular Carcinoma
STOCKHOLM, Oct. 5, 2023, Medivir AB (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that all patients in the ongoing phase 2a study in advanced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 5, 2023 Category: Pharmaceuticals Source Type: clinical trials

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Conditions: Locally Advanced Alveolar Soft Part Sarcoma; Metastatic Alveolar Soft Part Sarcoma; Locally Advanced Non Small Cell Lung Cancer; Metastatic Non Small Cell Lung Cancer; Locally Advanced Small Cell Lung Cancer; Metastatic Small Cell Lung Cancer; Locally Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma; Locally Advanced Melanoma; Metastatic Melanoma Interventions: Drug: Atezolizumab Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
Conditions: Cancer; Solid Tumor; Thromboembolism; Cardiovascular Diseases; Immune System Diseases; Inflammatory Diseases; Colon Cancer; Breast Cancer; Prostate Cancer; Hepatocellular Carcinoma; Lung Cancer; Chemotherapy; Immunotherapy Interventions: Drug: Palbociclib; Drug: Rivaroxaban; Genetic: SNP Sponsors: Lebanese University; Haykel Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials

Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy
Conditions: End Stage Liver Disease; Acute Liver Failure; Acute-On-Chronic Liver Failure; Hepatocellular Carcinoma Interventions: Procedure: Donor hepatectomy Sponsors: King Faisal Specialist Hospital& Research Center Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)
Conditions: Carcinoma, Hepatocellular; Metabolic Syndrome Interventions: Procedure: Liver resection and simultaneous sleeve gastrectomy for HCC induced by metabolic syndrome; Procedure: Liver resection for HCC induced by metabolic syndrome Sponsors: Ospedale V. Fazzi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma With Portal Vein Tumor Thrombus(PVTT)
Conditions: Stage IIIA Hepatocellular Carcinoma Interventions: Combination Product: Radiotherapy combined with TKI and Anti-PD-1 Antibody Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials